Download PDF
- Novartis
- Overview
- Last Modified:
- May 26, 2025
- Company type:
- Public
- Industry:
- Healthcare
- Verified:
- No
- No of Employees:
- 100 001 +
- Stock Code:
- NOVN
- Download
- Signed Health Status Declaration Form
- Turnover $50m + ?:
- Yes
- Headquarters:
- Basel, Switzerland
- Public Interest Score:
- 750+
- Novartis
- General Information
Description
Novartis is a global healthcare company based in Switzerland, known for its innovative medicines and treatments. The company focuses on reimagining medicine to improve and extend people’s lives. Novartis operates in various therapeutic areas, including oncology, cardiovascular, immunology, dermatology, and neuroscience.
- Acquisition of MorphoSys: Novartis recently acquired the German cancer biotech company MorphoSys for approximately $2.9 billion. As part of the integration, Novartis is closing MorphoSys sites in Munich and Boston, affecting around 330 jobs.
- Research and Development: Novartis continues to advance its R&D portfolio, focusing on prioritized programs and longer follow-up times for certain treatments.
   Operations
Novartis operates globally, reaching more than 250 million people worldwide with its medicines. The company is committed to making a positive impact by providing access to innovative treatments, protecting the environment, and upholding high ethical standards.
Simon Moroney:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Nancy Andrews:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Ton Buechner:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Patrice Bula:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Elizabeth Doherty:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Bridgette Heller:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Daniel Hochstrasser:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Frans van Houten:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Ana Gonzalo:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
John Young:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Charlotte Pamer-Wieser:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Giovanni Caforio:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Elizabeth McNally:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Nancy Andrews:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Ton Buechner:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Patrice Bula:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Elizabeth Doherty:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Bridgette Heller:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Daniel Hochstrasser:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Frans van Houten:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Ana Gonzalo:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
John Young:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Charlotte Pamer-Wieser:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Giovanni Caforio:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Elizabeth McNally:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Subsribe/ Login to view details on company risk rating
5 Benchmark > 4 Excellent > 3Â Good > 2 Caution > 1 Risk
- Company Information
- Company System Number:
- 15430
- Founded Year:
- 1996
- Registration Number:
- CHE-106.052.527
- Country:
- Switzerland
- Stock Exchanges:
-
- Swiss Stock Exchange
- Financial year end:
- December
- No. of Countries operations:
- 140
- Company Status:
- In Business
- Industry Sub Category:
- Date listed on Stock Exchange:
- 01/12/1996
- Contact Information
- Business operation:
- Novartis AG (Novartis) is a healthcare company that focuses on the discovery, development, manufacture and marketing of prescription and generic pharmaceutical products and eye care products. Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people's lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.
- Primary office:
- Lichtstrasse 35. CH-4056 Basel SWITZERLAND
- Additional Information
- Listed?:
- Yes
- Company secretary:
- Charlotte Pamer-Wieser
- Reporting currency:
- USD
- ISIN number (12 digit):
SWX
US66987V1098- Authorised shares:
- 2 189 930 497
- Issued shares:
- 2 077 000
- No of shareholders:
- 1001 and more shareholders
- No of shareholders holding 20%:
- 0 shareholders
- Number of shares traded
- Per Year:
- Per Quarter:
- Per Month:
Shareholders holding 5% +
For a comprehensive list, please contact InsidEntity.
Material Subsidiaries/Associates
For a comprehensive list, please contact InsidEntity.
Credit Rating
| Name | Logo | Country | Headquarters | Rating |
|---|---|---|---|---|
| Fitch | ![]() | United States of America | New York | AA- |
| Moody's | ![]() | United States of America | New York | Aa1 |
Countries Operations/ Offices
Company Directors
Name
Nationality
Age
Role
Qualification
Name
Bridgette
Non ExecutiveNationalityAmerican
65
RoleNED
QualificationBEcon, Master’s degree in marketing and management
Name
Charlotte
Non ExecutiveNationalitySwitzerland
2
RoleNED
QualificationLLM, PhD Law, Lincentiatus iuris
Directors Tenure
Name
Duration
Director Experience
Name
Experience
Name
Patrice
Experience
Environmental Services, Financial Services, Healthcare, Software and IT
Name
Bridgette
Experience
Environmental Services, Financial Services, Healthcare, Professional Firm, Software and IT
Name
Frans
Experience
Environmental Services, Financial Services, Healthcare, Professional Firm, Software and IT
Name
Ana
Experience
Environmental Services, Financial Services, Healthcare, Professional Firm
Company Auditors
Name
Date Appointed
Years
Name
KPMG
Date Appointed01/01/2017
Year9 years and 8 months
Company Past Directors
Name
ED/NED
Role
Company Committees
|
Committee
|
Abbreviation
|
|---|---|
|
Supervisory Board
|
SB
|
|
Board
|
BD
|
|
Risk & Compliance
|
RC
|
|
Audit
|
AU
|
|
Remuneration
|
RE
|
|
Capital investment
|
CI
|
|
Industry Specific
|
IS
|
|
Nominations & Governance
|
NG
|
|
Health, Safety & Environment
|
HS
|
|
Social & Ethics
|
SE
|
|
Technology
|
TE
|
|
Executive
|
EX
|
|
Other
|
OT
|






